Announcement on Litigation Involving the Company
Filed with SSE · · 3 pages · Chinese
Earlier from Getein Biotech
- Announcement on Outline of the Q3 2024 Online Performance Briefing
- Announcement on Resolutions of the 4th Meeting of the 4th Board of Supervisors
- Announcement on Termination of Listing on National Equities Exchange and Quotations by Holding Subsidiary Wuhan King Diagnostic Technology Co., Ltd.
- Announcement on Progress of the Company's Involvement in Litigation
- Announcement on the Convening of Online Briefing on 2024 Semi-annual Performance
Later from Getein Biotech
- Announcement on Result of Litigation Involving the Company
- Announcement on Changes in Accounting Policies
- Announcement on the Interim Dividend Distribution Arrangement in 2025
- Announcement on Share Reduction Plan for Shareholders
- Announcement on Resolution of the 2024 Annual General Meeting
Follow Getein Biotech into a list and get an email when it puts out news.
Follow Getein Biotech